Market Mover: Terns (TERN) Climbs at Midday June 22

Equities Staff  |

Today Terns Pharmaceuticals Inc (NASDAQ: TERN) is trading 6.19% higher.

The latest price, as of 12:10:42 est, was $2.06. Terns has risen $0.12 so far today.

47,315 shares exchanged hands.

As of the previous close, Terns has moved YTD 72.56%. The company expects its next earnings on 2022-08-15.

For technical charts, analysis, and more on Terns visit the company profile.

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.

To get more information on Terns Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Terns Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content